Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
EvaluatePharma World Preview 2018, Outlook to 2024
Report Highlights
- Worldwide prescription drug sales accelerate to $1.2 trillion by 2024, as unmet need drives annual compound growth to over 6%
- R&D spend is forecast at 16.9% of prescription sales in 2024, down from 20.9% in 2017
- Oncology continues to be a key industry driver, with a forecasted CAGR of 12% from 2017 to 2024
The latest annual World Preview 2018, Outlook to 2024 shows that orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market. The rare disease space is predicted to capture 20% of the total $1.2trn market in 2024.
Supporting this growth are the launches of novel therapies, including gene and cell therapies, as well as increased access to medicines globally.
This report brings together many of our analyses to provide a top level insight, from the world's financial markets, into the expected performance of the industry between now and 2024.